Explore evidence

463 patientsAmong dually seropositive patients, 463 were on antiretroviral therapy (ART).

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

25 %Nine out of 36 HIV-infected patients died, representing a mortality rate of 25%.

Côte d'IvoireVIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

7 casesOf the 1023 HIV-1-infected adults randomized in the Temprano deferred-ART group, seven (0.7%) were elite controllers.

Côte d'IvoireVIH/sidapublished 2022AIDS (London, England)europe_pmcdocument of 3 observations

1.42 per_100_person_monthsDuring the pre-intervention period, the malaria incidence rate was 1.42 cases per 100 person-months in the LLIN-alone control group.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

A multi-centric trial conducted in Kenya and Ethiopia reported no significant overall epidemiological impact of a Bti-based intervention on infection prevalence in school-aged children.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

25 monthsThe median follow-up duration was 25 months (interquartile range 19–31 months) among HBeAg-negative HIV/HBV co-infected patients in Côte d'Ivoire.

Côte d'Ivoirehépatite B · VIH/sidapublished 2019Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 4 observations

11 %The transmission dynamics model predicted a reduction in all-age clinical incidence of malaria of 11% to 78% across villages in Côte d'Ivoire.

Côte d'Ivoirepaludismepublished 2025PLoS pathogensPubMeddocument of 5 observations

14,480 deaths_per_yearAcross setting-scenarios, there was a mean of 14,480 deaths per year over 50 years with the switch policy in a setting with an adult population of 10 million in 2024.

Côte d'IvoireVIH/sidapublished 2025The lancet. HIVeurope_pmcdocument of 6 observations

40 %The intervention reduced malaria case prevalence by 40% in community cross-sectional surveys.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

1 per_100_person_weeksAmong children under five years of age, malaria incidence exceeded 1 case per 100 person-weeks during peaks in the late rainy season (November 2016).

Côte d'Ivoirepaludismeobserved November 2016HAL · Unilimdocument of 122 observations

3 casesThree cases of visceral leishmaniasis were reported in non-HIV infected native patients in Côte d'Ivoire.

Côte d'Ivoirevisceral leishmaniasispublished 2008Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 4 observations

7.92 aHRCavitation on chest x-ray was independently associated with mortality (aHR = 7.92, 95% CI, 1.74–35.94, p = .0073).

Côte d'Ivoiretuberculosepublished 2025BMC infectious diseaseseurope_pmcdocument of 9 observations

50.7 %A seropositivity to HIV1 and/or HIV2 was observed in 98 (50.7%) of patients with severe pulmonary tuberculosis in Ivory Coast from January to December 1987.

Côte d'IvoireHIV1 and/or HIV2observed 1987published 1989PubMedOpenAlexdocument of 10 observations

66.6 %QFT-GIT specificity for active TB was 66.6%.

Côte d'Ivoiretuberculosepublished 2014PloS oneeurope_pmcdocument of 8 observations

68.6 %68.6% of the patients were on antiretroviral therapy (ART).

Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations

25 %At month 12 after ART initiation, 25% of patients in active follow-up had detectable viral loads.

Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations

10,000 copies/mLChronic HBeAg-negative HBV infection phase was defined as HBV DNA ≤10,000 copies/mL and normal alanine aminotransferase (ALT).

Côte d'Ivoirehépatite Bpublished 2019Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 4 observations

135 individualsAmong 190 HBsAg-positive participants, 135 (71%) had HBV DNA+.

Côte d'Ivoirehépatite Bpublished 2021Antiviral therapyeurope_pmcdocument of 4 observations

26.6 %Only 34 patients (26.6%) returned for clinical and biological post-exposure follow-up with HIV control at third month, without documented seroconversion.

Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations

4 yearsMedian duration of antiretroviral therapy was 4 years.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations

82.9 %82.9% of AEB victims consulted before the 48th hour.

Côte d'Ivoireaccidental exposure to bloodobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

182 casesOne hundred eighty-two accidental exposures to blood (AEB) were managed over 6 years at the Infectious and Tropical Diseases Center of the Treichville University Hospital in Abidjan between January 2000 and December 2005.

Côte d'Ivoireaccidental exposure to bloodobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

14.5 %The prevalence of periodontitis among female sex workers in Abidjan, Côte d'Ivoire was 14.5%.

Côte d'Ivoireperiodontitisobserved 2013published 2015BMC oral healtheurope_pmcdocument of 7 observations

2.9 log10 copies/million PBMCThe median pre-antiretroviral treatment HIV-1 DNA level was 2.9 log10 copies per million PBMC among 1013 patients in the Temprano trial conducted in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2022BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/s12879-022-07082-2

18.3 %Undetermined infectious encephalitis accounted for 18.3% of causes of death.

Côte d'Ivoireundetermined infectious encephalitispublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations